Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment

Documenti analoghi

• Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
  di: Lotte G. Zuur, et al.
  Pubblicazione: (2025)
• Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
  di: Esther H. J. Hamoen, et al.
  Pubblicazione: (2025)
• The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen
  di: Cheng‐hao Guo, et al.
  Pubblicazione: (2025)
• The carbon footprint of transperineal prostate biopsy
  di: Daniel A. Carson, et al.
  Pubblicazione: (2025)
• Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
  di: Yuki Teramoto, et al.
  Pubblicazione: (2026)